United States · Bill · S
S. 959 (93rd)
A bill to amend the Federal Food, Drug, and Cosmetic Act, as amended, to require the submission of certain additional information by applicants for new drugs; to require the inclusion of certain additional information in drug labeling; and for other purposes.
Introduced
21 February 1973
Last action
—
Status
Referred to Senate Committee on Labor and Public Welfare.
Sponsors
—
Subjects
Discovery layer
Source updated
21 April 2025
Summary
Requires the submission of biological criteria and performance information by applicants for new drugs. Requires the inclusion of biological criteria relating to therapeutic effectiveness and safety.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Introduced in Senate
summary · EN · 21 February 1973
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/93rd-congress/senate-bill/959
- Open data entity: https://api.congress.gov/v3/bill/93/s/959